Pharmafile Logo

Video: Patient level prescribing decisions

February 9, 2016 | market research, patients 

Quantitative Director Duncan Munro explores the benefits of using patient level prescribing decisions.

There is no “one size fits all” approach to conducting demand assessments. The best studies utilise a methodology which is appropriate to the product in development, the market in which it will launch, and which gives the respondent the most realistic experience.  In this video, Duncan discusses the importance of using patient level prescribing data to better reflect doctor’s real world choices.

Watch the video:
www.researchpartnership.com/news/2016/01/video-patient-level-prescribing-decisions/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard